Medical Translation Company for Healthcare and Life Sciences

Medical translation is the professional translation of medical, clinical, healthcare and life sciences content by qualified subject-matter linguists. It covers medical device documentation, pharmaceutical materials, clinical trial content, patient-facing information, scientific literature and regulated documentation. Accurate medical translation requires linguistic competence, subject-matter knowledge, controlled terminology and structured review. It is typically delivered through ISO-based workflows that include translation, revision and QA, with certificates that identify the documents and linguists involved through tools such as CertLink for full project traceability.

Professional medical translation services are structured translation workflows handled by a medical translation company with qualified linguists, terminology resources and quality controls. They typically include risk-based service levels, ISO 17100 revision for higher-risk content, MDR/IVDR-aligned terminology and confidentiality safeguards. Professional services support regulatory, documentation and medical writing teams by reducing review burden, improving consistency across documents and providing audit-ready evidence through signed translation certificates. They do not replace internal regulatory, clinical or QMS responsibilities, which remain with the client organisation.

Medical document translation typically covers IFUs, labelling, CERs, PMCF documentation, regulatory submissions, clinical trial documents, informed consent forms, patient information leaflets, pharmacovigilance materials, pharmaceutical product information, scientific articles and healthcare provider content. It also includes UI strings, training materials and marketing content for medical devices and pharmaceuticals. Each document type carries specific terminology, regulatory and readability requirements, so the workflow is selected accordingly: lower-risk content may use translation plus QA, while higher-risk material follows full revision under ISO 17100.

Healthcare translation services are used by MedTech and pharmaceutical companies, healthcare providers, clinical research organisations, healthcare SaaS platforms, public health bodies, hospitals and patient organisations that operate across languages. Typical buyers include Regulatory Affairs Managers, Documentation Managers, Medical Writers, Clinical Affairs Managers, Pharmacovigilance Managers and Localization Managers. They need translation of regulated documentation, patient-facing materials, scientific content and operational content. Healthcare translation companies support these teams by providing qualified linguists, terminology control, confidentiality, traceability and workflows aligned with regulated environments and quality management systems.

Yes. AbroadLink delivers certified medical translation services supported by signed translation certificates identifying the documents, an internal project code and the translators involved. Where AI pre-translation has been used through aiHubLink, the certificate also indicates the AI model. Certificates remain accessible through CertLink for audits, QMS evidence and competent authority interactions. Certification supports transparency and traceability, but acceptance for specific legal, regulatory or institutional purposes depends on local rules, document type and the body receiving the translation, and remains a decision for the client and the relevant authorities.

Yes, but in a controlled way. Through aiHubLink, AbroadLink offers custom generative AI pre-translation that uses client terminology and legacy translations as references. The AI output is then fully reviewed and validated by qualified medical linguists under ISO 9001, ISO 17100 and ISO 13485-based processes. AI is positioned as a productivity layer to support consistency and turnaround times, not as a substitute for human medical judgement. For sensitive or safety-relevant medical content, the appropriateness of AI-assisted workflows is agreed with the client before the project begins.

AbroadLink manages medical terminology through glossaries, translation memories and terminology governance processes. For medical devices marketed in the European Union, we apply official terminology from Regulations (EU) 2017/745 (MDR) and 2017/746 (IVDR), along with glossaries derived from harmonised standards such as ISO 13485 and ISO 15223 where available. Client-specific terminology is captured, validated and reused across projects to support consistency between IFUs, labels, regulatory texts, clinical documents and patient-facing content over time.

No. Professional medical translation services support regulatory, clinical and documentation workflows by providing qualified linguistic execution, terminology control, review and traceable evidence through CertLink. However, regulatory approval, market access, QMS acceptance, clinical accuracy and legal validity depend on many factors beyond translation, including device design, regulatory strategy, scientific evidence and the assessment of competent authorities or notified bodies. AbroadLink does not replace the client's regulatory, clinical, medical writing, QARA, compliance, legal or notified body interactions, which remain the responsibility of qualified internal and external stakeholders.